Table 1.
ETU, EbolaTreatment Unit | In-House NP qRT-PCR | RealStar Filovirus | Ebola Xpert | All Tests Combined | ||||
---|---|---|---|---|---|---|---|---|
Months | Samples | Patients | Samples | Patients | Samples | Patients | Samples | Patients |
N+/Ntested (%) | N+/Ntested (%) | N+/Ntested (%) | N+/Ntested (%) | N+/Ntested (%) | N+/Ntested (%) | N+/Ntested (%) | N+/Ntested (%) | |
0–3 | 7/24 (29.2) | 6/19 (31.2) | 2/3 (66.7) | 1/2 (50.0) | 8/8 (100.0) | 7/7 (100.0) | 12/24 (50.0) | 10/19 (52.6) |
>3–6 | 4/28 (14.3) | 4/26 (15.4) | 2/14 (14.3) | 2/13 (15.4) | 10/14 (71.4) | 9/13 (69.2) | 13/34 (38.2) | 12/29 (41.4) |
>6–9 | 5/52 (9.6) | 5/47 (10.6) | 0/25 (0.0) | 0/20 (0.0) | 6/21 (28.6) | 5/18 (27.8) | 10/62 (16.1) | 9/54 (16.7) |
>9–12 | 1/76 (1.3) | 1/62 (1.6) | 0/51 (0.0) | 0/41 (0.0) | 6/37 (15.2) | 6/36 (16.7) | 7/107 (6.6) | 7/81 (8.7) |
>12–15 | 0/69 (0.0) | 0/61 (0.0) | 0/78 (0.0) | 0/69 (0.0) | 5/45 (11.1) | 5/45 (11.1) | 5/108 (4.6) | 5/93 (5.4) |
>15–18 | 1/51 (1.9) | 1/49 (2.1) | 1/86 (1.2) | 1/78 (1.3) | 1/45 (2.2) | 1/44 (2.3) | 1/111 (0.9) | 1/95 (1.1) |
>18–21 | 0/77 (0.0) | 0/76 (0.0) | 0/131 (0.0) | 0/110 (0.0) | 0/41 (0.0) | 0/39 (0.0) | 0/169 (0.0) | 0/137 (0.0) |
>21–24 | 0/80 (0.0) | 0/74 (0.0) | 0/93 (0.0) | 0/81 (0.0) | 0/9 (0.0) | 0/9 (0.0) | 0/143 (0.0) | 0/122 (0.0) |
>24–27 | 0/50 (0.0) | 0/50 (0.0) | 0/49 (0.0) | 0/49 (0.0) | 0/10 (0.0) | 0/10 (0.0) | 0/104 (0.0) | 0/101 (0.0) |
>27–30 | 0/20 (0.0) | 0/19 (0.0) | 0/40 (0.0) | 0/40 (0.0) | 0/18 (0.0) | 0/18 (0.0) | 0/76 (0.0) | 0/75 (0.0) |
>30–33 | 0/4 (0.0) | 0/4 (0.0) | 0/35 (0.0) | 0/34 (0.0) | 0/25 (0.0) | 0/25 (0.0) | 0/63 (0.0) | 0/63 (0.0) |
>33–36 | nd | nd | 0/15 (0.0) | 0/15 (0.0) | 0/54 (0.0) | 0/53 (0.0) | 0/69 (0.0) | 0/68 (0.0) |
>36–39 | nd | nd | nd | nd | 0/54 (0.0) | 0/54 (0.0) | 0/54 (0.0) | 0/54 (0.0) |
>39–42 | nd | nd | nd | nd | 0/59 (0.0) | 0/59 (0.0) | 0/59 (0.0) | 0/59 (0.0) |
>42–45 | nd | nd | nd | nd | 0/46 (0.0) | 0/46 (0.0) | 0/46 (0.0) | 0/46 (0.0) |
>45–48 | nd | nd | nd | nd | 0/65 (0.0) | 0/65 (0.0) | 0/65 (0.0) | 0/65 (0.0) |
>48–51 | nd | nd | nd | nd | 0/52 (0.0) | 0/52 (0.0) | 0/52 (0.0) | 0/52 (0.0) |
>51–54 | nd | nd | nd | nd | 0/15 (0.0) | 0/15 (0.0) | 0/15 (0.0) | 0/15 (0.0) |
>54–57 | nd | nd | nd | nd | 0/7 (0.0) | 0/7 (0.0) | 0/7 (0.0) | 0/7 (0.0) |
Total | 18/531 (3.4) | 14/225 (6.2) | 5/620 (0.8) | 3/243 (1.2) | 36/626 (5.8) | 23/238 (9.7) | 47/1368 (3.4) | 27/277 (9.8) |
Abbreviations: nd, not done; NP, nucleoprotein; qRT-PCR, quantitative reverse-transcription polymerase chain reaction; RNA, ribonucleic acid.